Old West Investment Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,068,719
| Closed | -$3.63M | – | 94 |
|
|
2018
Q3 | $3.63M | Buy |
1,068,719
+2,918
| +0.3% | +$10.5K | 1.5% | 24 |
|
|
2018
Q2 | $4.01M | Buy |
1,065,801
+444,415
| +72% | +$2.16M | 2.01% | 19 |
|
|
2018
Q1 | $2.54M | Sell |
621,386
-188
| -0% | -$875 | 1.46% | 25 |
|
|
2017
Q4 | $2.89M | Sell |
621,574
-89,338
| -13% | -$492K | 1.65% | 23 |
|
|
2017
Q3 | $5.05M | Sell |
710,912
-74,924
| -10% | -$539K | 2.65% | 15 |
|
|
2017
Q2 | $5.68M | Sell |
785,836
-43,078
| -5% | -$269K | 3.03% | 9 |
|
|
2017
Q1 | $5.11M | Buy |
828,914
+619,285
| +295% | +$3.39M | 2.71% | 14 |
|
|
2016
Q4 | $1.23M | Buy |
209,629
+73,405
| +54% | +$401K | 0.75% | 29 |
|
|
2016
Q3 | $723K | Buy |
136,224
+9,994
| +8% | +$53.9K | 0.53% | 38 |
|
|
2016
Q2 | $835K | Sell |
126,230
-1,390
| -1% | -$7.77K | 0.61% | 33 |
|
|
2016
Q1 | $595K | Buy |
127,620
+65,701
| +106% | +$262K | 0.5% | 40 |
|
|
2015
Q4 | $312K | Sell |
61,919
-15,485
| -20% | -$73.6K | 0.28% | 59 |
|
|
2015
Q3 | $272K | Sell |
77,404
-2,263
| -3% | -$15.2K | 0.21% | 64 |
|
|
2015
Q2 | $795K | Buy |
79,667
+36,326
| +84% | +$390K | 0.55% | 47 |
|
|
2015
Q1 | $551K | Buy |
43,341
+23,925
| +123% | +$308K | 0.37% | 64 |
|
|
2014
Q4 | $274K | Buy |
19,416
+418
| +2% | +$6.48K | 0.17% | 77 |
|
|
2014
Q3 | $261K | Buy |
+18,998
| New | +$291K | 0.16% | 76 |
|
Old West Investment Management's KERX Position: Q4 2018 in Review
Old West Investment Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 1,068,719 shares — an estimated $3.63M sold.
Old West Investment Management first reported a position in KERX in Q3 2014 and held it in 17 quarters. The position peaked at $5.68M in Q2 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Old West Investment Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Old West Investment Management sold 1,068,719 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $3.63M.
- Old West Investment Management first reported a position in Keryx Biopharmaceuticals Inc in Q3 2014 and held it in 17 quarters.
- Old West Investment Management's Keryx Biopharmaceuticals Inc position peaked at $5.68M in Q2 2017.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Old West Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.